ALISTROL - Lower High Blood Pressure Today!


Aloeride® - Aloe Vera Capsules

Bextra and Vioxx Withdrawal Spawn Advertising Pause from Bristol Myers


Pharmaceutical giant Bristol Myers Squibb has announced that they will suspend direct-to-consumer advertising for their prescription drug products for a year. This comes in the wake of the well-publicized withdrawals of Merck's Vioxx and Pfizer's Bextra, two non-steroidal anti-inflammatory drugs (NSAIDs) that were voluntarily withdrawn from the market recently. Studies showed that they increase the likelihood of strokes and heart attacks among patients that take them for prolonged periods of time. This represents an unusual move for a pharmaceutical company, as they tend to spend a large portion of their annual advertising budget on direct-to-consumer advertising.

It is possible that Bristol Myers recognizes that consumers are becoming concerned about new drugs being approved by the FDA and advertised heavily, only to find out later that the drugs have previously unknown and possibly dangerous side effects. Consumers have learned that advertising a drug as "new and improved" doesn't necessarily mean that it is new, or improved, or even safe. In short, customers are suspicious of pharmaceutical advertising, and the drug companies are to be commended for taking notice of that fact.

Since 1997, drug companies have been allowed by U.S. law to advertise directly to consumers. This has led to an astonishing number of ads on television and radio, as consumers see ads showing one happy person after another. The ads suggest that the happiness shown is a result of the use of the product, and a voiceover quickly mumbles through the known, and sometimes lengthy, list of side effects. Patients are encouraged to speak with their doctor, and they have been doing so in record numbers. The problem, as Bristol Myers know realizes, is that consumers are well aware that the withdrawn Bextra and Vioxx were advertised as being safe. This has naturally led to a general suspicion of all advertised drugs, and Bristol Myers correctly sees that they could be the victims of a drug-company backlash, even if they did not manufacture any of the withdrawn products.

This will probably save Bristol Myers a lot of money in the short term, as their advertising would have largely gone to waste. The Food and Drug Administration is taking steps to make sure that the drugs that reach the U.S. market are safe, and in time, the public will again become more trusting of pharmaceutical advertising. In the meantime, TV viewers will be spared from having to watch the sometimes-cryptic drug ads, which often prompt questions of "What does this drug do?"

©Copyright 2005 by Retro Marketing.

Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.

MFIII-Antiaging-Clinic


Roush Review: Good Medicine in Boston
Seattle Post Intelligencer
The TV medical drama may have hit hard times lately, with Mercy, Miami Medical and Three Rivers all limping off the air. But Boston Med (Thursday, 10/9c, ...

and more »


Sydney Morning Herald

Studies: CPR Without Rescue Breathing OK
WebMD
Rea's study, along with another head-to-head comparison of the two CPR approaches, is published in the New England Journal of Medicine. ...
The Day in MedicineKEYC
Compression CPR Found EffectiveLos Angeles Times
Evidence Supports AHA Recommendation for Hands-Only CPReMaxHealth
San Francisco Chronicle (blog) -Wall Street Journal -Voice of America
all 510 news articles »


A Novartis Giveaway of Medicine
New York Times
The Swiss drug giant Novartis plans to give away up to 250000 bottles of its new liquid children's medicine, Triaminic Fever Reducer Pain ...
Novartis Takes Swipe at J&JPortfolio.com (blog)
Why Novartis's Triaminic Giveaway Reminds Us of the Tour de FranceWall Street Journal (blog)

all 11 news articles »


Graymark Healthcare Continues to Advance Strategy to Become Nation's Top Sleep ...
PR Newswire (press release)
These agreements continue to execute on Graymark's strategy to expand the availability of sleep medicine in rural communities that otherwise might not have ...

and more »


Med Students: We Want More Sex Ed!
Wall Street Journal (blog)
That was our first question when we heard about a University of California, San Francisco study just published in Academic Medicine that ...
Study: Med Students Need More Sex (And More Sex Ed)AOL News

all 3 news articles »


Suresh named chair of anesthesiology at Baylor College of Medicine
BCM News
HOUSTON -- (July 29, 2010) -- Dr. Maya S. Suresh was named chair of the Department of Anesthesiology at Baylor College of Medicine by the college's board of ...
Following principles of new primary care model could reduce diagnostic errorsOrtho SuperSite

all 2 news articles »


Mexico's Two Biggest Parties Favor Expanding Sales Tax to Bolster Revenue
Bloomberg
Legislators from President Felipe Calderon's National Action Party, or PAN, may also expand the sales tax to food and medicine in their budget proposal, ...

and more »


Gossip Jackal

New England Journal of Medicine Publishes Data from Pivotal Phase 3 PROVENGE ...
PR Newswire (press release)
... in the New England Journal of Medicine, showing that PROVENGE® (sipuleucel-T) demonstrated a statistically significant improvement in overall survival ...
Costly New Prostate Cancer Drug Works In Mysterious WaysNPR (blog)
NEJM analyzes data on ProvengeFiercePharma
Dendreon's Prostate Cancer Drug Extends Life in Published StudyBusinessWeek
FierceVaccines -DG News -Forbes (blog)
all 42 news articles »


Lab Report: Health, Science and Medicine
TIME
Keeping young children on a stable schedule of activities--with consistent wake and sleep times, regular play periods ...



SADIF Analytics rates Zhejiang Medicine Co., Ltd. as an above average quality ...
PR-inside.com (press release)
2010-07-29 10:09:38 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to Zhejiang Medicine Co., Ltd. and produced a report, ...

and more »

Google News

Hibermate home | site map

© 2009 www.elearn-university.org